Kidney Disease: Early Detection, Management, and Prevention Tips

The Deutsche Gesellschaft für Nephrologie (DGfN) and the European Renal Association (ERA) have launched an early detection offensive to combat kidney diseases. This initiative focuses on an awareness campaign utilizing seminars and congresses to improve the identification of chronic kidney disease (CKD) at its earliest stages.

Early identification is considered a global imperative because CKD causes substantial global morbidity and increases both all-cause and cardiovascular mortality. The push for earlier detection is critical because early-stage CKD often presents with no signs or symptoms, meaning many individuals are unaware they have the condition until it has progressed significantly.

The Challenge of Silent Progression

According to data from the National Kidney Foundation, approximately 1 in 7 adults in the United States have CKD, and about 90% of those adults do not know they have the disease. Because the condition is often undetected until it is very advanced, patients may only discover the disease when they require a kidney transplant or dialysis.

The Centers for Disease Control and Prevention (CDC) notes that while early CKD has no symptoms, treating the condition earlier leads to better outcomes. If left unmanaged, kidney damage can progress to kidney failure, where the blood must be filtered through dialysis treatments several times a week.

High-Risk Populations and Prevention

Certain health conditions significantly increase the risk of developing kidney disease. The CDC reports that approximately 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure may have CKD. Other risk factors include heart disease, being overweight or obese, and a family history of CKD. Physical injuries and kidney infections can also cause the disease.

Managing these risk factors is a primary method of prevention. For individuals with diabetes, the CDC recommends getting tested for CKD yearly. Blood pressure-lowering medications may help people with diabetes prevent or delay the onset of the disease by reducing protein in the urine.

Tools for Early Identification

To support early detection, the International Society of Nephrology (ISN) and KDIGO have released a series of tools designed for kidney health professionals, nurses, and primary care physicians. These resources include the 2024 KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.

A specific toolbox has been developed to help healthcare providers start and sustain early CKD detection and intervention programs. This toolkit provides evidence-based resources and key principles to facilitate prompt action within primary care settings.

Recognizing Advanced Symptoms

While early stages are silent, advanced kidney disease may present with misleading or noticeable symptoms. The National Kidney Foundation identifies several potential trouble signs, including:

• Fatigue and weakness
• Foamy, pink, or dark urine (indicating blood in the urine)
• Difficult or painful urination
• Increased thirst and a more frequent need to urinate

Beyond kidney failure, the progression of CKD can lead to other severe health complications. These include heart disease, stroke, mineral and bone disorders, anemia, and neuropathy, as well as hyperkalemia, which is characterized by high levels of potassium in the blood.

Because having CKD increases the likelihood of heart disease and stroke, treatment focused on early intervention can help prevent or delay cardiovascular death and total kidney failure.